Recognized by America's Top Doctors, 2014 - 2018
Recognized by Best Doctors in America - 2013 - 2018
Recognized by Philadelphia magazine's annual Top Docs issues 2014 - 2019
Obstetrics and Gynecology - Gynecologic Oncology, 1999
Obstetrics and Gynecology, 1997
Abramson Cancer Center
Perelman Center for Advanced Medicine, West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
A facility of the Hospital of the University of Pennsylvania
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Katsakhyan L, Baraban EG, Dumoff KL, Burger RA, Parikh R, Cooper K: The “Far Left” of the Morphologic Spectrum of Ovarian High-Grade Serous Carcinoma: Case report of a Purely Non-invasive High-Grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor International Journal of Gynecological Pathology In Press : 2020.
Zamarin D, Burger RA, Sill MW, Powell DJ, Lankes HA, Zivanovic O, Gunderson C, Ko E, Mathews C, Sharma S, Hagemann AR, Khleif S, Aghajanian C: A Randomized Phase II Trial of Nivolumab vs. Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study J Clin Oncol In Press : 2020.
Coleman RL, Handley KF, Burger RA, Dal Molin G, Stagg R, Sood A, Moore K.: Demcizumab combined with paclitaxel for platinum-resistant ovarian, primary peritoneal, and fallopian tube cancer: The SIERRA open-label phase Ib trial Gynecol Oncol In Press : 2020.
Nasioudis D, Sakamuri S, Ko EM, Haggerty AF, Giuntoli R, Burger RA, Morgan MA, Latif NA: Radical hysterectomy is not associated with a survival benefit for patients with stage II endometrial carcinoma Gynecol Oncol In Press : 2020.
Wade K, Brady MF, Thai T, Want Y, Zheng B, Salani R, Tewari KS, Gray HJ, Bakkum-Gamez JN, Burger RA, Moore KN, Bookman MA: Measurements of adiposity as prognostic biomarkers for survival with anti-angiogenic treatment in epithelial ovarian cancer: An NRG Oncology/Gynecologic Oncology Group ancillary data analysis of GOG 218 Gynecol Oncol 155 (1): 69 - 74,2019.
Oved JH, Graul A, Burger RA, Schwartz LE, Reyes MC, Balis FM.: Exceptional Response to Nivolumab in a 13 year old female with metastatic HPV Negative Cervical Carcinoma DNA and Cell Biology 38 (10): 1143 - 1146,2019.
Tewari KT, Burger RA, Enserro D, Norquist BM, Swisher EM, Brady MF, Bookman MA, Fleming GF, Huang H, Homesley HD, Fowler JM, Greer BE, Boente M, Liang SX, Ye C, Bais C, Randall LM, Chan JK, Ferriss JS, Coleman RL, Aghajanian C, Herzog TJ, DiSaia PJ, Copeland LJ, Mannel RS, Birrer MJ, Monk BJ.: Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer. J Clin Oncol 37 (26): 2317 - 2328,2019.
Fuh K, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS: Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients Gynecol Oncol 154 (2): 420 - 425,2019.
Fruehauf JP, Parmakhtiar B, Burger RA, Kim J-H: HIF inactivation of p53 in Ovarian Cancer Can be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity Molecular Cancer Research 17 (8): 1675 - 1686,2019.
Cori L, Cha B, Ellenberg S, Bogner HR, Hwang W-T, Smith J, Haggerty A, Morgan M, Burger R, Chu C, Ko E: Effects of Educational Interventions on Human Papillomavirus Vaccine Acceptability: A Randomized Controlled Trial
Obstetrics and Gynecology 134 (2): 376 - 384,2019.
University of Pennsylvania3400 Civic Center Blvd.South Tower 10-173
Phone: (215) 220-9513
Patient appointments: 800-789-7366